• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • Fairs & Events
  • MedicalMountains & Cisema Webinar: “Made in China” Current regulatory trends and requirements

MedicalMountains & Cisema Webinar: “Made in China” Current regulatory trends and requirements

Made in China Current regulatory trends
Thursday, 25 August 2022 / Published in Fairs & Events, News, Webinars

MedicalMountains & Cisema Webinar: “Made in China” Current regulatory trends and requirements

“Made in China” current regulatory trends and requirements for medtech manufacturers will be presented in this webinar, held together with MedicalMountains GmbH on October 6, 2022.

China medical device registration approvals are increasing each year. In 2021, 11,314 medical device registrations were approved, of which over 1,700 were new initial registrations. Medtech manufacturers have to deal intensively with the regulatory requirements. The constant further development of regulations for approval and post-market surveillance make it essential to deal with the topic on an ongoing basis. The current “Made in China” requirements pose further challenges that require the localization of the products and the establishment of a Market Authorization Holder (MAH).

The focus of this event covers both aspects – Regulatory Affairs Updates and MAH from a regulatory point of view. 

Click here for detailed information about the webinar.

Date and Time

October 6, 2022, 9:00am (Germany time)

Program Content

  • Secure access to the Chinese market
  • Regulatory requirements of today and tomorrow
  • Fit for “Made in China” – requirements to obtain the label
  • Flexibility in localization  
  • Implementation of a Market Authorization Holder (MAH)

Speaker

Mr. Stefan Fischer – Managing Director of the Cisema Group

Language

The webinar will be conducted in German.

Our Services

The process of China NMPA registration is complex, and can take from a few months to several years, depending on the product. The costs and the exact timeframe of the registration process varies, among all, on its classification and the testing required. 

Even experienced companies could encounter unforeseen challenges. Our committed consultants can guide you through China’s regulatory processes, from identifying product classifications and preparing the application documents in Chinese to approval and issue of the NMPA certificate.

Cisema specializes in bypassing clinical trials in China. If clinical trials are mandated, Cisema can define the clinical trial criteria for your product, identify and coordinate with accredited laboratories, and ensure compliance with all regulations. The NMPA approval for medical devices is valid for 5 years. Learn more about the process of China NMPA registration including timeline and how Cisema avoids clinical trials in our brochures or contact Cisema directly.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

China IVD Reagent Registration and Review Guidelines
China IVD Reagent Registration and Review Guidelines Updates have been issued
Energy efficiency labeling requirements for electric motors
Important News Concerning CCC Marking

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.